Australia injects $10.1 M to back next-generation of medical researchers

Singapore, Jan. 9 -- The Australian government is investing $10.1 million to support the next generation ofhealth and medical researchers. Through the NHMRC Postgraduate Scholarships scheme, 67 outsta... Read More

Pierre Fabre Laboratories Bets On Generative AI With Iktos To Reimagine The Future Of Oncology Drug Discovery

Singapore, Jan. 9 -- Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, announced an integrated drug discovery collaboration to identi... Read More

Sectra begins implementation of first digital pathology project in Japan

Singapore, Jan. 8 -- Sweden-based medical technology and cybersecurity company Sectra, in collaboration with distribution partner Matsunami Glass, has commenced the implementation phase of its first d... Read More

Kyorin and Lunatus partner to launch Lasvic tablets in nine Middle Eastern countries

Singapore, Jan. 8 -- Japan's Kyorin Pharmaceutical has entered into an exclusive distribution agreement with Lunatus Marketing & Consulting FZCO for Lasvic tablets (Lascufloxacin hydrochloride). Publ... Read More

Xellar, Woojung Bio to advance AI-enabled organ-on-a-chip preclinical models

Singapore, Jan. 8 -- US-based startupXellar Biosystems, a globally leading innovator in next-generation artificial intelligence (AI)- and computer vision-assisted, organ-on-a-chip-based drug discovery... Read More

Iktos And Servier Enter Strategic AI Led Drug Discovery Collaboration Valued At Over €1 Billion

Singapore, Jan. 8 -- Iktos, a leader in Artificial Intelligence (AI) and Robotics applied to drug discovery, announced a landmark multi-target collaboration agreement with Servier, an international in... Read More

Australia's Avance Clinical strengthens global oncology offering with acquisition of LumaBridge

Singapore, Jan. 7 -- Avance Clinical, a full-service Australia headquartered contract research organisation (CRO) focused on accelerating clinical development for biotech sponsors, has announced the a... Read More

Sanofi announces sales transfer of anticancer agent JEVTANA to Taiho in Japan

Singapore, Jan. 6 -- Sanofi K.K. and Taiho Pharmaceutical have announced that the sales of the anticancer agent Jevtana(R) I.V. Infusion 60 mg will be transferred from Sanofi to Taiho in Japan effecti... Read More

Pandorum Technologies and Nucelion Therapeutics focus on treating ocular diseases in APAC region

Singapore, Jan. 6 -- Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmable tissue regeneration, has announced a strategic collabora... Read More

Taiwan's ScinoPharm secures US FDA approval of Glatiramer Acetate Injection for MS treatment

Singapore, Jan. 5 -- ScinoPharm Taiwan has announced a landmark achievement in the global pharmaceutical landscape, securing US Food and Drug Administration (FDA) approval for Glatiramer Acetate Injec... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»